Literature DB >> 35361723

The Non-Inferiority Complex: What Do Non-Inferiority Trials Tell Us?

Magdalene M Assimon1, Gary R Cutter2, Joanne M Bargman3.   

Abstract

Entities:  

Keywords:  nephrology; noninferiority trials; study design

Mesh：

Year:  2022        PMID： 35361723      PMCID： PMC8970441          DOI： 10.1681/ASN.2021050681

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   14.978


× No keyword cloud information.
  8 in total

1.  Good enough: a primer on the analysis and interpretation of noninferiority trials.

Authors:  Sanjay Kaul; George A Diamond
Journal:  Ann Intern Med       Date:  2006-07-04       Impact factor: 25.391

2.  Current issues in non-inferiority trials.

Authors:  Thomas R Fleming
Journal:  Stat Med       Date:  2008-02-10       Impact factor: 2.373

3.  How to use a noninferiority trial: users' guides to the medical literature.

Authors:  Sohail M Mulla; Ian A Scott; Cynthia A Jackevicius; John J You; Gordon H Guyatt
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

Review 4.  Challenges in the Design and Interpretation of Noninferiority Trials.

Authors:  Laura Mauri; Ralph B D'Agostino
Journal:  N Engl J Med       Date:  2017-10-05       Impact factor: 91.245

5.  Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.

Authors:  Kai-Uwe Eckardt; Rajiv Agarwal; Ahmad Aswad; Ahmed Awad; Geoffrey A Block; Marcelo R Bacci; Youssef M K Farag; Steven Fishbane; Harold Hubert; Alan Jardine; Zeeshan Khawaja; Mark J Koury; Bradley J Maroni; Kunihiro Matsushita; Peter A McCullough; Eldrin F Lewis; Wenli Luo; Patrick S Parfrey; Pablo Pergola; Mark J Sarnak; Bruce Spinowitz; James Tumlin; Dennis L Vargo; Kimberly A Walters; Wolfgang C Winkelmayer; Janet Wittes; Rafal Zwiech; Glenn M Chertow
Journal:  N Engl J Med       Date:  2021-04-29       Impact factor: 91.245

6.  Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.

Authors:  Steven Fishbane; Carol A Pollock; Mohamed El-Shahawy; Elizabeth T Escudero; Anjay Rastogi; Bui Pham Van; Lars Frison; Mark Houser; Maksym Pola; Dustin J Little; Nicolas Guzman; Pablo E Pergola
Journal:  J Am Soc Nephrol       Date:  2022-04       Impact factor: 10.121

7.  Defining the noninferiority margin and analysing noninferiority: An overview.

Authors:  Turki A Althunian; Anthonius de Boer; Rolf H H Groenwold; Olaf H Klungel
Journal:  Br J Clin Pharmacol       Date:  2017-04-06       Impact factor: 4.335

8.  Non-adherence in non-inferiority trials: pitfalls and recommendations.

Authors:  Yin Mo; Cherry Lim; James A Watson; Nicholas J White; Ben S Cooper
Journal:  BMJ       Date:  2020-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.